FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2086071454> ?p ?o ?g. }

• W2086071454 endingPage "446" @default.
• W2086071454 startingPage "441" @default.
• W2086071454 abstract "Background We report the outcomes of a single-center experience with endovascular aneurysm repair (EVAR) in nonagenarians. Methods Via a retrospective medical records review, we identified all patients ≥90 years old who underwent EVAR at a single university teaching hospital during a 5-year period (January 2004 to December 2008). Patients were evaluated for surgical risk factor profile, preoperative imaging, technical success, postoperative complications, length of hospital stay, and need for secondary intervention. In addition, mortality rates were evaluated at 30 days, 365 days, and 2 years. Results There were 18 nonagenarians (12 male, 67%) with a mean age of 91.2 years (range 90-95). Each patient averaged 3.5 risk factors, and the mean preoperative maximal aneurysm size was 68.3 mm (range 50-105). Sixteen (89%) patients were treated on an elective basis, and two patients were emergently treated for aneurysm rupture, with one undergoing aortouni-iliac stenting with femoral–femoral bypass. All other patients in the study had bifurcated stent grafts. There was 100% technical success with no need for open conversion. The mean length of hospital stay was 4.3 days with a mean intensive care unit stay of 0.6 days. Systemic complications occurred in three patients (17%) including one death within 30 days. Secondary interventions were required in two patients (11%). One had endovascular treatment of a type I endoleak at 4 months, and a second patient underwent femoral–femoral bypass at 25 months for severe flow-limiting limb angulation. Mortality rates were 5.6% at 30 days, 41.2% at 365 days, and 58.3% at 2 years. Mean survival of the 11 patients who expired beyond the first 30 days was 17.5 months (range 4-50). Of these, mean survival of the nine patients treated electively was 20.2 months (range 7-50). Mean survival of the six patients still alive is 25.6 months (range 8-65). Conclusion EVAR is safe in nonagenarians despite their advanced age and significant surgical risk factor profile. The procedure can be performed with excellent technical success and a low rate of perioperative complications. However, mortality rates after 30 days are significant. The substantial long-term mortality raises the question of possible treatment futility in this unique population. While age should not be a contraindication for EVAR, recommendations for the procedure should be based on individual patient selection. We report the outcomes of a single-center experience with endovascular aneurysm repair (EVAR) in nonagenarians. Via a retrospective medical records review, we identified all patients ≥90 years old who underwent EVAR at a single university teaching hospital during a 5-year period (January 2004 to December 2008). Patients were evaluated for surgical risk factor profile, preoperative imaging, technical success, postoperative complications, length of hospital stay, and need for secondary intervention. In addition, mortality rates were evaluated at 30 days, 365 days, and 2 years. There were 18 nonagenarians (12 male, 67%) with a mean age of 91.2 years (range 90-95). Each patient averaged 3.5 risk factors, and the mean preoperative maximal aneurysm size was 68.3 mm (range 50-105). Sixteen (89%) patients were treated on an elective basis, and two patients were emergently treated for aneurysm rupture, with one undergoing aortouni-iliac stenting with femoral–femoral bypass. All other patients in the study had bifurcated stent grafts. There was 100% technical success with no need for open conversion. The mean length of hospital stay was 4.3 days with a mean intensive care unit stay of 0.6 days. Systemic complications occurred in three patients (17%) including one death within 30 days. Secondary interventions were required in two patients (11%). One had endovascular treatment of a type I endoleak at 4 months, and a second patient underwent femoral–femoral bypass at 25 months for severe flow-limiting limb angulation. Mortality rates were 5.6% at 30 days, 41.2% at 365 days, and 58.3% at 2 years. Mean survival of the 11 patients who expired beyond the first 30 days was 17.5 months (range 4-50). Of these, mean survival of the nine patients treated electively was 20.2 months (range 7-50). Mean survival of the six patients still alive is 25.6 months (range 8-65). EVAR is safe in nonagenarians despite their advanced age and significant surgical risk factor profile. The procedure can be performed with excellent technical success and a low rate of perioperative complications. However, mortality rates after 30 days are significant. The substantial long-term mortality raises the question of possible treatment futility in this unique population. While age should not be a contraindication for EVAR, recommendations for the procedure should be based on individual patient selection." @default.
• W2086071454 created "2016-06-24" @default.
• W2086071454 creator A5001143892 @default.
• W2086071454 creator A5021369727 @default.
• W2086071454 creator A5028497944 @default.
• W2086071454 creator A5037541501 @default.
• W2086071454 creator A5050638660 @default.
• W2086071454 creator A5062107169 @default.
• W2086071454 creator A5065816864 @default.
• W2086071454 creator A5075931249 @default.
• W2086071454 date "2010-05-01" @default.
• W2086071454 modified "2023-10-16" @default.
• W2086071454 title "Acceptable Risk but Small Benefit of Endovascular Aneurysm Repair in Nonagenarians" @default.
• W2086071454 cites W1838534864 @default.
• W2086071454 cites W1972051055 @default.
• W2086071454 cites W1976240350 @default.
• W2086071454 cites W2010377377 @default.
• W2086071454 cites W2015306497 @default.
• W2086071454 cites W2015544299 @default.
• W2086071454 cites W2024641271 @default.
• W2086071454 cites W2039005801 @default.
• W2086071454 cites W2043165772 @default.
• W2086071454 cites W2045973048 @default.
• W2086071454 cites W2050771230 @default.
• W2086071454 cites W2055961166 @default.
• W2086071454 cites W2057671585 @default.
• W2086071454 cites W2057697492 @default.
• W2086071454 cites W2060570114 @default.
• W2086071454 cites W2077523233 @default.
• W2086071454 cites W2090099381 @default.
• W2086071454 cites W2122348272 @default.
• W2086071454 cites W2138439841 @default.
• W2086071454 cites W2157200938 @default.
• W2086071454 cites W2158891368 @default.
• W2086071454 doi "https://doi.org/10.1016/j.avsg.2009.10.009" @default.
• W2086071454 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20036490" @default.
• W2086071454 hasPublicationYear "2010" @default.
• W2086071454 type Work @default.
• W2086071454 sameAs 2086071454 @default.
• W2086071454 citedByCount "21" @default.
• W2086071454 countsByYear W20860714542012 @default.
• W2086071454 countsByYear W20860714542013 @default.
• W2086071454 countsByYear W20860714542014 @default.
• W2086071454 countsByYear W20860714542015 @default.
• W2086071454 countsByYear W20860714542016 @default.
• W2086071454 countsByYear W20860714542017 @default.
• W2086071454 countsByYear W20860714542020 @default.
• W2086071454 countsByYear W20860714542021 @default.
• W2086071454 crossrefType "journal-article" @default.
• W2086071454 hasAuthorship W2086071454A5001143892 @default.
• W2086071454 hasAuthorship W2086071454A5021369727 @default.
• W2086071454 hasAuthorship W2086071454A5028497944 @default.
• W2086071454 hasAuthorship W2086071454A5037541501 @default.
• W2086071454 hasAuthorship W2086071454A5050638660 @default.
• W2086071454 hasAuthorship W2086071454A5062107169 @default.
• W2086071454 hasAuthorship W2086071454A5065816864 @default.
• W2086071454 hasAuthorship W2086071454A5075931249 @default.
• W2086071454 hasConcept C126322002 @default.
• W2086071454 hasConcept C141071460 @default.
• W2086071454 hasConcept C167135981 @default.
• W2086071454 hasConcept C195910791 @default.
• W2086071454 hasConcept C2776098176 @default.
• W2086071454 hasConcept C2776376669 @default.
• W2086071454 hasConcept C2776543907 @default.
• W2086071454 hasConcept C2778583881 @default.
• W2086071454 hasConcept C2779993416 @default.
• W2086071454 hasConcept C2780120127 @default.
• W2086071454 hasConcept C71924100 @default.
• W2086071454 hasConceptScore W2086071454C126322002 @default.
• W2086071454 hasConceptScore W2086071454C141071460 @default.
• W2086071454 hasConceptScore W2086071454C167135981 @default.
• W2086071454 hasConceptScore W2086071454C195910791 @default.
• W2086071454 hasConceptScore W2086071454C2776098176 @default.
• W2086071454 hasConceptScore W2086071454C2776376669 @default.
• W2086071454 hasConceptScore W2086071454C2776543907 @default.
• W2086071454 hasConceptScore W2086071454C2778583881 @default.
• W2086071454 hasConceptScore W2086071454C2779993416 @default.
• W2086071454 hasConceptScore W2086071454C2780120127 @default.
• W2086071454 hasConceptScore W2086071454C71924100 @default.
• W2086071454 hasIssue "4" @default.
• W2086071454 hasLocation W20860714541 @default.
• W2086071454 hasLocation W20860714542 @default.
• W2086071454 hasOpenAccess W2086071454 @default.
• W2086071454 hasPrimaryLocation W20860714541 @default.
• W2086071454 hasRelatedWork W1980858832 @default.
• W2086071454 hasRelatedWork W2029272552 @default.
• W2086071454 hasRelatedWork W2135308080 @default.
• W2086071454 hasRelatedWork W2162824165 @default.
• W2086071454 hasRelatedWork W2287051346 @default.
• W2086071454 hasRelatedWork W2411609798 @default.
• W2086071454 hasRelatedWork W2559894681 @default.
• W2086071454 hasRelatedWork W3024587250 @default.
• W2086071454 hasRelatedWork W3142373072 @default.
• W2086071454 hasRelatedWork W4235420789 @default.
• W2086071454 hasVolume "24" @default.
• W2086071454 isParatext "false" @default.
• W2086071454 isRetracted "false" @default.
• W2086071454 magId "2086071454" @default.

• next